Nevertheless, upon sulfarotene treatment, RARα and SOS2 were observed to co-localize in the nucleuses of HCC TRCs, even though the expression of SOS2 decreased (Fig. 5a), indicating an inverse association between SOS2 and RARα. The gene discussed is RARA; the disease is hepatocellular carcinoma.